Fig. 4.
Time course of recombinant human erythropoietin (rHuEPO) serum concentrations (a) and percentage of reticulocytes counts (b) following subcutaneous administration of rHuEPO at different doses. The lines and the shaded area represent the median and 90% prediction interval from the posterior predictive check, respectively.
